Design, synthesis and biological evaluation of proline-arginine rich hybrid peptides against ESKAPE pathogens by inhibiting bacterial protein synthesis and DNA replication
Bioorganic Chemistry · 2026-09 · 179 · 110012
DOI: 10.1016/j.bioorg.2026.110012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-09. Verfasst von Aman Kumar Mahto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard (Deemed to be University), 110062, Indi…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Design, Proline, Antimicrobial Peptides. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Indian Council of Medical Research, Council of Scientific & Industrial Research, Science and Engineering Research Board.
Abstract (Originalsprache)
The rise of multidrug-resistant (MDR) bacteria, particularly ESKAPE pathogens, has led to the widespread failure of traditional antibiotics, highlighting the urgent need for novel therapeutics. Proline-arginine rich antimicrobial peptides (PrAMPs) have emerged as promising candidates due to their broad-spectrum activity, high cell selectivity, and a lower frequency of resistance development compared to conventional drugs. A strategic target for new antibacterial agents is the bacterial sliding clamp (DnaN), a central component of the DNA replisome. In this study, we designed a series of novel hybrid peptides inspired by a known PrAMP sequences, covalently linked to a peptide inhibitor of DnaN. These hybrids were synthesized via solid-phase peptide synthesis and evaluated against a panel of Gram-positive and Gram-negative bacteria, including MDR strains. Within this library, NHP-13 was identified as the lead analogue, demonstrating potent antimicrobial activity with Minimum Inhibitory Concentrations (MICs) ranging from 15.6 to 125 μM. NHP-13 utilizes a -RRR- (tri-arginine) linker to combine ribosomal-inhibiting and nucleic acid inhibiting sequences. Mode-of-action studies confirmed that NHP-13 functions through intracellular accumulation and inhibition of protein synthesis. Crucially, the peptide showed a non-hemolytic and non-cytotoxic characteristics against mammalian cell lines. Furthermore, the in vivo efficacy was validated in a murine infection model, where NHP-13 showed bacterial clearance of nearly 2 log colony-forming units (CFU) in the tested organs. These results underscore the potential of intracellular hybrid AMPs as safe, effective, and resilient antimicrobial agents for clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard (Deemed to be University), 110062, India.
- Department of Pharmacognosy & Phytochemistry, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard (Deemed to be University), 110062, India.
- Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard (Deemed to be University), 110062, India. Electronic address: rpdewangan@jamiahamdard.ac.in.
Förderung
- Indian Council of Medical Research
- Council of Scientific & Industrial Research
- Science and Engineering Research Board
- Council for Scientific and Industrial Research, South Africa
- University Grants Commission
Zitieren
APA
Mahto, A. K., Sharma, S., Kanupriya, Tripathi, G., Aeri, V., Yar, M. S., & Dewangan, R. P. (2026). Design, synthesis and biological evaluation of proline-arginine rich hybrid peptides against ESKAPE pathogens by inhibiting bacterial protein synthesis and DNA replication. Bioorganic Chemistry, 179, 110012. https://doi.org/10.1016/j.bioorg.2026.110012
Vancouver
Mahto AK, Sharma S, Kanupriya, Tripathi G, Aeri V, Yar MS, et al. Design, synthesis and biological evaluation of proline-arginine rich hybrid peptides against ESKAPE pathogens by inhibiting bacterial protein synthesis and DNA replication. Bioorganic Chemistry. 2026;179:110012. doi:10.1016/j.bioorg.2026.110012
BibTeX
@article{Mahto2026,
author = {Mahto, Aman Kumar and Sharma, Saumya and Kanupriya and Tripathi, Garima and Aeri, Vidhu and Yar, M Shahar and Dewangan, Rikeshwer Prasad},
title = {Design, synthesis and biological evaluation of proline-arginine rich hybrid peptides against ESKAPE pathogens by inhibiting bacterial protein synthesis and DNA replication},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {179},
pages = {110012},
doi = {10.1016/j.bioorg.2026.110012}
}
EUVIMED